Glyburide Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Aug 10, 2026 · last update Aug 10, 2026
Manufacturers: Sanofi-Aventis U.S. LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Diabeta, Tablet, 5 mg (NDC 0093-9364-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Aug 10, 2026 Updated Aug 10, 2026 Discontinued Aug 10, 2026 |
| Diabeta, Tablet, 5 mg (NDC 0093-9364-10) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Aug 10, 2026 Updated Aug 10, 2026 Discontinued Aug 10, 2026 |
| Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Aug 10, 2026 Updated Aug 10, 2026 Discontinued Aug 10, 2026 |
| Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Aug 10, 2026 Updated Aug 10, 2026 Discontinued Aug 10, 2026 |